A federal appeals court last week reversed an order by a district court certifying a class action of insurers, labor unions, and pension funds who all
Continue Reading Federal Appeals Court Vacates Third Party Payor Class Certification
pharmaceutical
State Court Affirms Exclusion of Expert Evidence in Accutane Case
By Sean Wajert on
Posted in Articles
A New Jersey appellate court recently affirmed a trial court’s decision that an Accutane plaintiff’s expert’s study must be excluded as unreliable. Se…
Continue Reading State Court Affirms Exclusion of Expert Evidence in Accutane Case
PhRMA Issues New Principles on Clinical Trials
By Sean Wajert on
Posted in Articles, Drug and Device
Readers of MassTortDefense know how the conduct and results of clinical trials can reach out and affect later product liability litigation: plaintiffs…
Continue Reading PhRMA Issues New Principles on Clinical Trials
Canadian Court Rejects Pharmaceutical Class Action
By Sean Wajert on
We have posted before about just how difficult Canada is becoming as a jurisdiction for class actions defendants, particularly companies in the pharma…
Continue Reading Canadian Court Rejects Pharmaceutical Class Action